Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.


Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
15 06 2020
Historique:
pubmed: 6 2 2020
medline: 8 10 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

Brain protein biomarker clearance to blood in traumatic brain injury (TBI) is not fully understood. The aim of this study was to analyze the effect that a disrupted blood-brain barrier (BBB) had on biomarker clearance. Seventeen severe TBI patients admitted to Karolinska University Hospital were prospectively included. Cerebrospinal fluid (CSF) and blood concentrations of S100 calcium binding protein B (S100B) and neuron-specific enolase (NSE) were analyzed every 6-12 h for ∼1 week. Blood and CSF albumin were analyzed every 12-24 h, and BBB integrity was assessed using the CSF:blood albumin quotient (Q

Identifiants

pubmed: 32013731
doi: 10.1089/neu.2019.6741
pmc: PMC7249468
doi:

Substances chimiques

Biomarkers 0
S100 Calcium Binding Protein beta Subunit 0
S100B protein, human 0
Phosphopyruvate Hydratase EC 4.2.1.11

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1381-1391

Subventions

Organisme : NINDS NIH HHS
ID : R03 NS114335
Pays : United States
Organisme : CIHR
ID : 432061
Pays : Canada

Références

Clin Chem Lab Med. 2006;44(9):1111-4
pubmed: 16958605
Neurol Res. 2015 Jul;37(7):599-606
pubmed: 25749458
Neurocrit Care. 2014 Apr;20(2):217-29
pubmed: 24146416
J Neurotrauma. 2009 Sep;26(9):1497-1507
pubmed: 19257803
Nat Rev Neurol. 2010 Jul;6(7):393-403
pubmed: 20551947
J Neurotrauma. 2010 Jan;27(1):51-64
pubmed: 19698072
Cancer. 2003 Jun 1;97(11):2806-13
pubmed: 12767094
Acta Neurochir (Wien). 2011 Jan;153(1):90-100
pubmed: 20686797
Int J Biochem Cell Biol. 2001 Jul;33(7):637-68
pubmed: 11390274
BMJ. 2008 Feb 23;336(7641):425-9
pubmed: 18270239
Crit Care Med. 2001 Jun;29(6):1116-23
pubmed: 11395585
BMC Med. 2013 Feb 25;11:50
pubmed: 23432764
J Neurotrauma. 2019 Oct 15;36(20):2850-2862
pubmed: 31072225
Cardiovasc Psychiatry Neurol. 2010;2010:801295
pubmed: 20671945
Front Neurol. 2014 Sep 02;5:159
pubmed: 25228896
Restor Neurol Neurosci. 2003;21(3-4):79-96
pubmed: 14530572
Methods Mol Biol. 2011;686:101-31
pubmed: 21082368
Neurosurgery. 2001 Jun;48(6):1255-8; discussion 1258-60
pubmed: 11383727
Clin Chim Acta. 1989 Jul 31;183(1):13-31
pubmed: 2548772
PLoS One. 2013;8(3):e56805
pubmed: 23483891
Acta Neurochir (Wien). 2017 Feb;159(2):209-225
pubmed: 27957604
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Neurosci Biobehav Rev. 2016 Sep;68:460-473
pubmed: 27181909
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Ann Thorac Surg. 2000 Mar;69(3):750-4
pubmed: 10750755
J Trauma. 1974 Mar;14(3):187-96
pubmed: 4814394
Lancet. 1975 Mar 1;1(7905):480-4
pubmed: 46957
J Neurotrauma. 2011 Dec;28(12):2453-62
pubmed: 21428722
NeuroRehabilitation. 2007;22(5):341-53
pubmed: 18162698
J Neurosurg Anesthesiol. 1994 Jan;6(1):4-14
pubmed: 8298263
Restor Neurol Neurosci. 2003;21(3-4):109-21
pubmed: 14530574
J Trauma. 1988 Jan;28(1):69-77
pubmed: 3123707
Brain Res Bull. 2003 Aug 15;61(3):281-5
pubmed: 12909298
BMC Neurosci. 2007 Jan 02;8:2
pubmed: 17199889
Fluids Barriers CNS. 2011 Jan 18;8(1):2
pubmed: 21349150
J Neurotrauma. 2013 Jun 1;30(11):946-57
pubmed: 23190274
Int J Biol Markers. 2005 Jan-Mar;20(1):34-42
pubmed: 15832771
Adv Exp Med Biol. 2015;867:125-43
pubmed: 26530364
Lancet Neurol. 2017 Dec;16(12):987-1048
pubmed: 29122524
Neurocrit Care. 2014 Apr;20(2):209-16
pubmed: 24233818
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
J Neurosci. 2015 Jan 14;35(2):518-26
pubmed: 25589747
J Neurotrauma. 2013 Apr 1;30(7):519-28
pubmed: 23297751
Crit Care. 2016 Sep 08;20:285
pubmed: 27604350
Front Neurol. 2017 Jul 03;8:300
pubmed: 28717351
Neurology. 1998 May;50(5):1388-91
pubmed: 9595992
Stroke. 1998 Nov;29(11):2363-6
pubmed: 9804649
J Neurosci. 2003 Mar 1;23(5):1949-55
pubmed: 12629200
J Neurotrauma. 1992 Mar;9 Suppl 1:S287-92
pubmed: 1588618
Sci Rep. 2018 May 8;8(1):7194
pubmed: 29740121
Scand J Clin Lab Invest. 1977 Sep;37(5):385-90
pubmed: 337459
J Trauma. 1993 Feb;34(2):216-22
pubmed: 8459458
Front Psychol. 2017 Apr 07;8:456
pubmed: 28439244
Brain. 2017 Oct 1;140(10):2691-2705
pubmed: 28969373
Fluids Barriers CNS. 2016 Nov 30;13(1):21
pubmed: 27903281
Neurosurgery. 2005 Dec;57(6):1173-82; discussion 1173-82
pubmed: 16331165
Brain Res. 2002 Jun 14;940(1-2):102-4
pubmed: 12020881
Front Neurol. 2018 Jan 26;9:15
pubmed: 29434566
J Exp Med. 2015 Jun 29;212(7):991-9
pubmed: 26077718
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):362-9
pubmed: 8774396

Auteurs

Caroline Lindblad (C)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

David W Nelson (DW)

Department of Section for Perioperative Medicine and Intensive Care, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Frederick A Zeiler (FA)

Section of Neurosurgery, Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, and University of Manitoba, Winnipeg, Manitoba, Canada.
Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, Manitoba, Canada.
Centre on Aging, University of Manitoba, Winnipeg, Manitoba, Canada.
Division of Anaesthesia, Department of Medicine, and Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Ari Ercole (A)

Division of Anaesthesia, Department of Medicine, and Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Per Hamid Ghatan (PH)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Henrik von Horn (H)

Department of Division of Clinical Chemistry, and Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Mårten Risling (M)

Department of Neuroscience, and Karolinska Institutet, Stockholm, Sweden.

Mikael Svensson (M)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurosurgery, Karolinska Institutet, Stockholm, Sweden.

Denes V Agoston (DV)

Department of Neuroscience, and Karolinska Institutet, Stockholm, Sweden.
Department of Anatomy, Physiology and Genetics, Uniformed Services University, Bethesda, Maryland, USA.

Bo-Michael Bellander (BM)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurosurgery, Karolinska Institutet, Stockholm, Sweden.

Eric Peter Thelin (EP)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Department of Theme Neuro, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH